Predict your next investment

Healthscope company logo
HEALTHCARE | Medical Facilities & Services / Hospitals
healthscope.com.au

See what CB Insights has to offer

Founded Year

1985

Stage

Take Private | Alive

Total Raised

$10.8M

Valuation

$0000 

About Healthscope

Healthscope is an Australian company which operates private hospitals, medical centers and international pathology services.

Healthscope Headquarter Location

312 St Kilda Road

Melbourne, Victoria, 300,

Australia

03 9926 7500

Latest Healthscope News

TPG chooses banks for $800 mil IPO of its Pathology Asia Holdings

Mar 29, 2021

​ Bloomberg Published on Fri, Mar 26, 2021 / 5:39 PM GMT+8 / Updated 2 days ago A- A+ TPG Capital Asia has picked banks to help prepare an initial public offering of its pathology business in the region that could raise as much as $800 million in Singapore, according to people with knowledge of the matter.The private equity firm is working with Citigroup Inc. and CIMB Group Holdings Bhd. on the planned first-time share sale of Pathology Asia Holdings Pte, said the people. Credit Suisse Group AG and DBS Group Holdings Ltd. are also working on the offering, they said, asking not to be named as the process is private. A listing in the city-state could take place as soon as the end of this year, the people said.Pathology Asia joins renewable energy firm Sunseap Group Pte, Thai Beverage Pcl’s brewery unit and City Developments Ltd.’s UK asset real estate investment trust in seeking an IPO in Singapore. The country has only seen one new listing this year, according to data compiled by Bloomberg. Aztech Global Ltd. raised about US$224 million ($301.8 million) in an offering this month.Deliberations are ongoing and the size and timing of the IPO could change, said the people. Representatives for Citi, CIMB, Credit Suisse, DBS and TPG declined to comment.TPG reached out to prospective advisers for proposals on the pathology unit IPO, Bloomberg News reported earlier this month. The buyout firm has grown the business from its initial 39 pathology laboratories, which TPG purchased from Healthscope Ltd. in 2018 for A$279 million ($285.4 million), a person familiar with the matter has said. It is now worth about US$2 billion, the person said. Get the latest Singapore corporate news stories for FREE This field is required Please check your email inbox to confirm your newsletter subscription. TPG Capital Asia manages about US$9.9 billion in assets, according to its website. The arm of global buyout firm TPG has offices in Beijing, Hong Kong, Melbourne, Mumbai, and Singapore.Pathology Asia Holdings, originally formed out of the Healthscope purchase, includes the Quest Laboratories brand in Singapore and Vietnam, and Gribbles Pathology in Malaysia. It announced the acquisition of Singapore’s Innovative Diagnostics Pte in 2018, and bought a minority stake in Australian drug testing company Safe Work Laboratories Pty the following year. Unlimited access to all stories from $99.9/year* The latest reporting and analysis from business and investments to news and views on social issues. Bonus:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Healthscope Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Healthscope Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.